Home/Filings/4/0001209191-22-005558
4//SEC Filing

Leavitt Chase C. 4

Accession 0001209191-22-005558

CIK 0001260990other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:00 PM ET

Size

6.1 KB

Accession

0001209191-22-005558

Insider Transaction Report

Form 4
Period: 2022-01-27
Leavitt Chase C.
General Counsel/Secretary
Transactions
  • Purchase

    Common Stock

    2022-01-28$1.63/sh+5,000$8,15044,867 total
  • Purchase

    Common Stock

    2022-01-27$1.78/sh+8,500$15,13039,867 total

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother

Related Parties

1
  • filerCIK 0001777467

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:00 PM ET
Size
6.1 KB